文献速递重症综合管理与镇静镇痛

重症存活者长期肌无力分子基础:肌肉转录组改变

Altered muscle transcriptome as molecular basis of long-term muscle weakness in survivors from critical illness.
PubMed 文献 · Intensive Care Med · 2025-06-10
一句话结论重症存活者5年后肌肉RNA表达异常,提示线粒体功能受损、脂代谢紊乱和纤维化,与长期肌力下降相关,部分与ICU内早期肠外营养和糖皮质激素使用相关。

该研究为EPaNIC试验的预计划二次分析,比较115例前ICU患者5年后与30例匹配对照的肌肉转录组(RNA测序),并做通路过表达和差异共表达分析。调整年龄、性别和BMI后,前患者有234个RNA下调、116个上调。通路和分子组织学分析提示线粒体能量代谢受损、脂代谢紊乱和胶原形成/纤维化增加。异常RNA表达与较低长期肌力相关;ICU内早期肠外营养和糖皮质激素使用与异常RNA表达相关。结论认为这些异常表达谱提示线粒体功能破坏、脂代谢紊乱和纤维化,与长期肌力下降相关,部分归因于可能可避免的危险因素,为预防和可能治疗长期肌无力提供视角。

要点

  • 重症存活者5年后肌肉转录组仍有234个RNA下调和116个上调(调整年龄、性别、BMI后)。
  • 通路分析提示线粒体能量代谢受损、脂代谢紊乱和胶原形成/纤维化增加。
  • 异常肌肉RNA表达与较低长期肌力相关。
  • ICU内早期肠外营养和糖皮质激素使用与异常RNA表达相关,为可能可避免的危险因素。
  • 这些发现为预防和可能治疗重症后长期肌无力提供新视角。

适用人群与场景

  • 需ICU住院的重症患者,5年后随访;对照为匹配的30例非ICU患者。
  • 该分析为EPaNIC试验的预计划二次分析,纳入115例前ICU患者和30例匹配对照。

研究设计与关键结果

  • 研究类型:EPaNIC试验的预计划二次分析,比较115例前ICU患者5年后与30例匹配对照的肌肉转录组(RNA测序),并做通路过表达和差异共表达分析。
  • 主要结果:调整年龄、性别和BMI后,前患者有234个RNA下调和116个上调。
  • 通路和分子组织学分析提示线粒体能量代谢受损、脂代谢紊乱和胶原形成/纤维化增加。
  • 异常肌肉RNA表达与较低长期肌力相关。
  • ICU内早期肠外营养和糖皮质激素使用与异常RNA表达相关。

证据类型、等级与局限

  • 证据类型:预计划二次分析(基于EPaNIC试验),采用RNA测序、通路过表达和差异共表达分析、多变量线性回归。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些发现为预防和可能治疗重症后长期肌无力提供了视角。
  • ICU内早期肠外营养和糖皮质激素使用与异常RNA表达相关,提示可能可避免的危险因素。

指南或共识出处

  • EPaNIC试验,ClinicalTrials.gov-NCT00512122,注册日期2007年7月31日。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Critically ill patients requiring intensive care unit (ICU) admission suffer from muscle weakness that persists for years, compromising quality-of-life. The pathophysiology of this long-term weakness remains unclear. We hypothesized that former ICU-patients show a long-term abnormal RNA-expression profile, which may contribute to lower long-term strength and for which modifiable risk factors can be identified.

METHODS: This pre-planned secondary analysis of the EPaNIC-trial compared muscle transcriptomes of 115 former ICU-patients 5 years after critical illness and 30 matched controls with RNA-sequencing, followed by pathway over-representation and differential co-expression analyses of the differentially expressed RNAs. We used multivariable linear regression analyses to identify which of the abnormal RNA-expressions associated with the long-term muscle strength of the patients and to identify potential risk factors for the abnormal RNA-expressions.

RESULTS: In former patients, 234 down-regulated and 116 up-regulated RNAs were identified after adjustment for age, sex, and BMI. Pathway over-representation and further molecular and histological analyses indicated impaired mitochondrial energy metabolism, disturbed lipid metabolism, and increased collagen formation/fibrosis in former patients. Abnormal muscle RNA-expression in former patients correlated with lower long-term muscle strength. Several treatments given in-ICU and at 5-year follow-up associated with abnormal RNA-expression, most notably in-ICU early parenteral nutrition (early PN) and glucocorticoid use.

CONCLUSION: Abnormal RNA-expression profiles 5 years after critical illness suggest disrupted mitochondrial function, disturbed lipid metabolism, and fibrosis, associated with lower long-term muscle strength and partly attributable to possibly avoidable risk factors. These findings open perspectives for prevention and possibly treatment of long-term muscle weakness after critical illness.

TRIAL REGISTRATION NUMBER AND DATE: ClinicalTrials.gov-NCT00512122, July 31, 2007.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Uzun Ayar C, Güiza F, Derese I, et al. Altered muscle transcriptome as molecular basis of long-term muscle weakness in survivors from critical illness. Intensive Care Med. 2025. PMID: 40493222. doi:10.1007/s00134-025-07949-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。